Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule

Research output: Contribution to journalArticle

Authors

Colleges, School and Institutes

Abstract

Until recently, randomized studies of implantable cardioverter defibrillator (ICD) have only included patients with a remote history of myocardial infarction (MI). Two studies evaluated the use of ICDs early following MI, the DINAMIT and BEST+ICD studies, but failed to demonstrate significant reduction in mortality. Current guidelines therefore recommend deferring ICD implantation for at least 40 days following MI. This article highlights the limitations of these two studies and reviews the application of the '40-day' rule to patients with acute MI.

Details

Original languageEnglish
Pages (from-to)536-9
Number of pages4
JournalEuropace
Volume10
Issue number5
Early online date7 Apr 2008
Publication statusPublished - 7 Apr 2008